Targeting Inflammatory Kinase as an Adjuvant Treatment for Osteosarcomas

BACKGROUND: A subset of patients with aggressive osteosarcomas responds poorly to conventional cytotoxic chemotherapy. Recent evidence from studies involving the liver, skin, stomach, and colon suggests that carcinogenesis is associated with inflammation. Mitogen-activated protein kinase (MAPK)/extr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Bone Joint Surg Am
Autors principals: Noh, Kyucheol, Kim, Kyung-Ok, Patel, Neel R., Staples, J. Robert, Minematsu, Hiroshi, Nair, Kumar, Young-In Lee, Francis
Format: Artigo
Idioma:Inglês
Publicat: The Journal of Bone and Joint Surgery, Inc. 2011
Matèries:
Scientific Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6882535/
https://ncbi.nlm.nih.gov/pubmed/21508279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2106/JBJS.J.00302
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars